Menu

MANAGEMENT

EMIL BILLBÄCK

CHIEF EXECUTIVE OFFICER

EMIL BILLBÄCK

CHIEF EXECUTIVE OFFICER

Emil Billbäck has more than 20 years’ experience in commercial operations within the life science industry - 11 years of which gained in senior leadership positions under private equity ownership (Montagu and EQT). Most recently, he was Senior Advisor to the recently merged BSN medical/ SCA entity. Before the merger he was Executive Vice President EMEA and Head of Global Commercial Operations, at BSN medical. Prior to this Emil held several roles at BSN medical as Interim President North America, Group Director Commercial Operations, Group Director R&D and President APAC. Before joining BSN medical, Emil worked at Beiersdorf and AstraZeneca. While Swedish native, Emil has lived and worked 4 years in the US and more than 9 years in Germany. He holds a BSc in Business Administration from Karlstad University.

BJÖRN WESTBERG

CHIEF FINANCIAL OFFICER

BJÖRN WESTBERG

CHIEF FINANCIAL OFFICER

Björn Westberg joined the Company as Chief Financial Officer in January 2017 from Recipharm AB (publ) - one of the largest pharmaceutical contract manufacturers in the world - where he was CFO since 2007. Prior to this Mr Westberg was CFO of the listed (Nasdaq Stockholm) software company Jeeves (2001-2007). Before that he held senior roles at AstraZeneca, among those Finance Director ISMO Northern Europe and Controller in Astra Japan.

Holdings in BONESUPPORT: 1,250,000 warrants.

CARIN NILSSON-THORELL

VP QUALITY MANAGEMENT & REGULATORY AFFAIRS

CARIN NILSSON-THORELL

VP QUALITY MANAGEMENT & REGULATORY AFFAIRS

Carin Nilsson-Thorell has overall responsibility for global quality and regulatory compliance. She has been VP, Quality & Regulatory Management, at BONESUPPORT AB since 2002. She holds an MSc in Chemical Engineering (1979) with academic post graduate courses in Medical Device Technology (Clinical Chemistry); Pharmacology and Toxicology. Carin previously managed pre-clinical and clinical qualification of immune therapy medical devices at Glycorex Transplantation (2001-2002). Prior to this she worked at Gambro AB in various international positions within medical device development and qualification including a position as Director for Microbiology, Toxicology and Clinical Affairs (1980-2000); and as Laboratory Engineer at Clinical Chemistry lab at University Hospital (1978-1980).

Holdings in BONESUPPORT: 225,295 employee stock options.

MICHAEL DIEFENBECK

EVP R&D, MEDICAL & CLINICAL AFFAIRS CHIEF MEDICAL OFFICER

MICHAEL DIEFENBECK

EVP R&D, MEDICAL & CLINICAL AFFAIRS CHIEF MEDICAL OFFICER

Dr. Diefenbeck joined BONESUPPORT AB in April 2017. In 2014 he founded Scientific Consulting in Orthopaedic Surgery and worked for BONESUPPORT AB on different projects as an independent clinical advisor. He is currently honorary consultant at Nuffield Orthopaedic Centre, Oxford University Hospitals. Dr. Diefenbeck studied medicine at Munich and was trained as an orthopaedic surgeon, specializing in trauma care and bone infections. He has 14 years’ clinical experience at different German hospitals (BG Unfallklinik Murnau, BG Kliniken Bergmannstrost Halle/Saale, University Hospital Jena and Schön Klinik Hamburg Eilbek). At University Hospital Jena he finished his PhD in 2011 and has since been involved in surgical education and training programs for students. He is author of 24 Pub-med listed research articles.

Holdings in BONESUPPORT: 360,000 employee stock options.

VIKRAM JOHRI

GENERAL MANAGER & EXECUTIVE VP COMMERCIAL OPERATIONS EUROW

VIKRAM JOHRI

GENERAL MANAGER & EXECUTIVE VP COMMERCIAL OPERATIONS EUROW

Mr Johri develops and manages international sales with a focus on exponential revenue growth. He holds an MBA in Marketing from Syracuse University (1993) and a Bachelors of Commerce from Dehli University (1988). Prior to his current role, Mr Johri was Chief Commercial Officer (2009-2012), and prior to joining BONESUPPORT AB, was VP of EMEA Wright Medical (2007-2009) and Group Marketing Manager International at Boston Scientific 2002-2009.

Holdings in BONESUPPORT: 1,005,812 employee stock options.

PATRICK O'DONNELL

GENERAL MANAGER & EXECUTIVE VP COMMERCIAL OPERATIONS NORTH AMERICA

PATRICK O'DONNELL

GENERAL MANAGER & EXECUTIVE VP COMMERCIAL OPERATIONS NORTH AMERICA

Patrick O’Donnell has a proven track record in the medical device, biologics, and biomaterials industries - with technologies in the orthopedic, spine, neurosurgery, sports medicine, interventional radiology, vascular and, metabolic disorders markets – gained over the past 24 years. Mr. O’Donnell most recently served as the Founder, Director, and Chief Executive Officer of ProteoThera, Inc., an early stage biotech company with matrix-binding protein fusion technology for local delivery of small molecules and proteins to address articular joint inflammatory diseases. Prior to this he held the position of CEO at several organizations including EndoSphere Inc, Histogenics Corporation and Prochon BioTech; and the Director of Global Marketing at Confluent Surgical. Mr. O’Donnell began his career at J & J DePuy Spine where he worked for thirteen years in commercial positions of escalating responsibility. Mr. O’Donnell graduated from the University of Wisconsin-Madison.

Holdings in BONESUPPORT: 720,000 employee stock options.

HELENA BRANDT

HEAD OF HUMAN RESOURCES

HELENA BRANDT

HEAD OF HUMAN RESOURCES

Helena L Brandt is a senior HR leader with more than 20 years’ experience gained from a broad range of industries. Ms Brandt has held global HR leadership roles at Astra Zeneca, Sony and Tetra Pak, developing organizational leadership and teams. She holds an International Business & Economics Master’s Degree from Lund University, Sweden, and also studied at the University of Cologne in Germany and at the universities of Cincinnati and Delaware in the U.S.

LINDA BUTCHER

CHIEF MARKETING OFFICER

LINDA BUTCHER

CHIEF MARKETING OFFICER

Linda Butcher joined BONESUPPORT AB in 2010 and is responsible for global marketing strategies and activities. Prior to this she worked in sales and product specialist roles for Schneider UK (1990-1998). From 1998 to 2010 she was European Marketing Manager and International Marketing Manager for Boston Scientific. Linda is a Registered General Nurse (RGN) and was previously VP Global Marketing, BONESUPPORT AB (2010-2016).

Holdings in BONESUPPORT: 421,550 employee stock options.

JOHAN OLSSON

CHIEF OPERATING OFFICER

JOHAN OLSSON

CHIEF OPERATING OFFICER

Johan Olsson is responsible for supply chain and holds an MSc in Mechanical Engineering (1991) from Lund University. He joined BONESUPPORT AB in 2007 as production and logistics Director, and before then he worked for Gambro as Head of the Intensive Care Line (2000-2007), where he was responsible, amongst other things, for the transfer of Gambro's production in Italy to Sweden. Before that, Johan held a number of different logistics, purchasing and manufacturing management positions in various consumer product companies.

Holdings in BONESUPPORT: 165,295 employee stock options.